Yuanyuan Qiao

15PUBLICATIONS
102CO-AUTHORS
Health and ecological risk assessmentPredictive and prognostic markersMolecular targetsInnate immunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 26, 2026
A dual role of EZH2 in regulating A-to-I RNA editing and mRNA stability through ADAR.

Yang Yi, Yanqiang Li, Rui Wang

|Oct 03, 2025
Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer.

Jie Luo, Zhixiang Chen, Yuanyuan Qiao

|Jun 12, 2025
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinoma.

Jean Ching-Yi Tien, Yali Zhai, Rong Wu

|Apr 24, 2025
Targeting PIKfyve-driven lipid metabolism in pancreatic cancer.

Caleb Cheng, Jing Hu, Rahul Mannan

|Nov 14, 2024
The UBA1-STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade.

Yi Bao, Gabriel Cruz, Yuping Zhang

|Sep 09, 2024
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis.

Abhijit Parolia, Sanjana Eyunni, Brijesh Kumar Verma

Pageof 3

Frequent Collaborators

13 joint publications

Arul M Chinnaiyan

10 joint publications

Rahul Mannan

7 joint publications

Rui Wang

5 joint publications

Yang Zheng